Status:
UNKNOWN
Efficacy of Gamified Cognitive Control Training Using de:)Press on Depression Severity add-on to Treatment as Usual
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Depression
Cognitive Impairment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Depression is one of the most frequent and devastating psychiatric diseases with a substantial bur-den for patients and society. It is specifically associated with dysfunctional activity in brain netw...
Eligibility Criteria
Inclusion
- Male, female, diverse,
- age \>= 18,
- informed consent,
- sufficient understanding of German (native speaker or CEFR level B skills or higher),
- unipolar depression diagnosed according to ICD-10 (F32.0, F32.1, F32.2 or F33. 0, F32.1, F32.2).
- consultation with a physician due to depressive symptomatology within the last 6 months
Exclusion
- Inability to give consent,
- inability to use de:)press® on a tablet or smartphone,
- acute suicidality,
- schizophrenia (F20),
- brief psychotic disorder (F23),
- schizoaffective disorder (F25),
- mental disorders due to known physiological conditions (F00 - F09),
- major depressive disorder, single episode, severe with psychotic features (F32.3),
- major depressive disorder, recurrent, severe with psychotic features (F33.3),
- Intellectual disability (F70 - F79).
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT05385614
Start Date
May 1 2022
End Date
June 1 2023
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Tübingen
Tübingen, Baden-Wurttemberg, Germany, 72076